Assessing the Value Proposition of NUWIQ® in the Hemophilia A Market: An Illustrative Model in Cost AvoidanceSeptember 2, 2020
Cost-Effective Treatment Option for von Willebrand DiseaseApril 1, 2019HematologyDrug TherapyEmergency Medicine
